stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Palisade Bio IncPALI
$1.121.75%-0.02
Pre-market: 1.11-0.01 -0.89%

Palisade Bio Inc (PALI)

Palisade Bio Inc stock is traded at $1.12, with a volume of 1,460,064. It is down -1.75% in the last 24 hours and down -20.57% over the past month. Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Previous Close:
$1.14
Open:
$1.15
24h Volume:
1,460,064
Relative Volume:
0.40
Market Cap:
$201.02M
Revenue:
$250.00K
Net Income/Loss:
-$24.15M
P/E Ratio:
-
EPS:
-$1.07
Net Cash Flow:
-$12.40M
1W Performance:
-5.88%
1M Performance:
-20.57%
6M Performance:
-38.80%
1Y Performance:
-47.66%
1-Day Range:
$1.08$1.15
1-Week Range:
$1.08$1.20
52-Week Range:
$1.08$2.86

Palisade Bio Inc Stock (PALI) Company Profile

Name
Palisade Bio Inc
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, USA
Employee
14
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
PALI's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Palisade Bio Inc Stock (PALI) Financials Data

Similar to PALI